p16+ Oropharyngeal Cancer Radiation Optimization Trial Reducing Elective Treatment Volumes (PROTEcT)

Volume and Dose De-Intensified Radiotherapy for p16+ Squamous Cell Carcinoma of the Oropharynx: A Multi-Centre, Single Arm Prospective Cohort Study

Trial Details

NCT ID
NCT04104945
Phase
NA
Sponsor
AHS Cancer Control Alberta
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • De-intensified chemoradiotherapy
Locations (sample)
  • Calgary, Alberta, Canada|51.05011,-114.08529

Key Eligibility Criteria

  • Age 18 or older
  • Provide informed consent
  • ECOG performance status 0-2
  • Histologically confirmed squamous cell carcinoma

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →